.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC30_AcetylsalicylicAcidAndDipyridamo.AcetylsalicylicAcidAndDipyridamo .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC30_AcetylsalicylicAcidAndDipyridamo.AcetylsalicylicAcidAndDipyridamo| name: | AcetylsalicylicAcidAndDipyridamoleCombination |
| ATC code: | B01AC30 |
| route: | oral |
| n-compartments | 1 |
This combination includes acetylsalicylic acid (aspirin) and dipyridamole, both of which are antithrombotic agents. It is used to reduce the risk of stroke in patients with a history of transient ischemic attacks or completed thrombotic stroke. The combination is approved and marketed in many countries, often as an extended-release oral formulation.
Pharmacokinetic parameters estimated for healthy adults; no dedicated population PK publication available.